CyberLogic, Inc.

Clinical Validation Contact Us

Clinical Validation Summary

UltraScan 650 — FDA‑Approved, Radiation‑Free Bone Densitometry with DXA‑Equivalent Accuracy


View Clinical References

Overview

UltraScan 650 is an FDA‑approved ultrasound bone densitometer designed for fast, radiation‑free assessment of bone mineral density (BMD). Its accuracy and reproducibility have been validated through multiple clinical studies comparing UltraScan 650 measurements with gold‑standard DXA results.



Direct BMD Measurement Using NTD Technology

UltraScan 650 uses CyberLogic’s patented Net Time Delay (NTD) ultrasound technology. Unlike traditional QUS devices that estimate bone quality indirectly, NTD enables direct measurement of bone mineral density, producing results that correlate strongly with DXA.

  • Direct BMD measurement
  • High signal stability
  • Low operator dependency
  • Strong correlation with DXA BMD, T‑scores and Z-scores
  • High reproducibility


Clinical Accuracy Compared to DXA

Multiple clinical studies have shown that UltraScan 650 provides DXA‑equivalent accuracy for forearm‑site bone density assessment.

  • Strong correlation with DXA BMD
  • High sensitivity for detecting low bone density
  • High specificity for identifying normal bone density
  • Consistent performance across age groups and genders


Reproducibility & Precision

UltraScan 650 exhibits excellent reproducibility, making it reliable for follow‑up measurements and long‑term monitoring.

  • Low coefficient of variation (CV)
  • High intra‑operator reproducibility
  • High inter‑operator reproducibility
  • Stable measurements in mobile screening environments


Radiation‑Free Screening

UltraScan 650 uses no ionizing radiation, making it ideal for primary care, women’s health, endocrinology, preventive medicine, and mobile screening programs.



Clinical Use Cases

  • Primary care osteoporosis screening
  • Endocrinology and metabolic bone clinics
  • Women’s health and menopause centers
  • Preventive medicine and community screening
  • Occupational health monitoring


Summary of Published Evidence

UltraScan 650’s clinical performance is supported by:

  • Peer‑reviewed journal articles
  • Independent validation studies
  • Comparative studies with DXA
  • Technical papers on NTD ultrasound modeling
  • Longitudinal monitoring studies

Full list of publications:

View Clinical References


UltraScan 650 vs Traditional QUS Devices

Feature UltraScan 650 Traditional QUS
Measurement Type Direct BMD (g/cm2) Indirect estimate
Accuracy DXA‑equivalent Lower correlation
Technology Patented Net Time Delay (NTD) Broadband ultrasound
Radiation None None

Full comparison:

Compare UltraScan 650 vs MiniOmni


Request Clinical Documentation

If your clinic or research group requires validation papers, technical specifications, workflow guides, or comparison data, please contact us.

Contact CyberLogic